Untreated atrial fibrillation in the United States of America : Understanding the barriers and treatment options

Atrial fibrillation is the most commonly treated arrhythmia in the United States of America. Stroke is the most devastating consequence of atrial fibrillation. For decades, warfarin has been the most recommended treatment for patients with atrial fibrillation at risk for stroke and systemic emboli....

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Journal of the Saudi Heart Association. - 1999. - 27(2015), 1 vom: 28. Jan., Seite 44-9
1. Verfasser: Verdino, Ralph J (VerfasserIn)
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2015
Zugriff auf das übergeordnete Werk:Journal of the Saudi Heart Association
Schlagworte:Journal Article Review Anticoagulation Atrial fibrillation
LEADER 01000naa a22002652 4500
001 NLM245087044
003 DE-627
005 20231224140118.0
007 cr uuu---uuuuu
008 231224s2015 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jsha.2014.09.003  |2 doi 
028 5 2 |a pubmed24n0817.xml 
035 |a (DE-627)NLM245087044 
035 |a (NLM)25561824 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Verdino, Ralph J  |e verfasserin  |4 aut 
245 1 0 |a Untreated atrial fibrillation in the United States of America  |b Understanding the barriers and treatment options 
264 1 |c 2015 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 06.01.2015 
500 |a Date Revised 29.09.2020 
500 |a published: Print-Electronic 
500 |a Citation Status PubMed-not-MEDLINE 
520 |a Atrial fibrillation is the most commonly treated arrhythmia in the United States of America. Stroke is the most devastating consequence of atrial fibrillation. For decades, warfarin has been the most recommended treatment for patients with atrial fibrillation at risk for stroke and systemic emboli. However, many patients at risk are not treated with anticoagulants. Several reasons exist, including physician underestimation of patient stroke risk, physician overestimation of bleeding risk, and patients' reluctance to take chronic warfarin due to the difficulties of this medication in relation to its pharmacokinetics and interactions with food and other medications. Risk scores have helped to better define patient risks and benefits from chronic anticoagulation. Novel anticoagulants (NOACs) have improved the ability for patients to be compliant with anticoagulation 
650 4 |a Journal Article 
650 4 |a Review 
650 4 |a Anticoagulation 
650 4 |a Atrial fibrillation 
773 0 8 |i Enthalten in  |t Journal of the Saudi Heart Association  |d 1999  |g 27(2015), 1 vom: 28. Jan., Seite 44-9  |w (DE-627)NLM098225227  |x 1016-7315  |7 nnns 
773 1 8 |g volume:27  |g year:2015  |g number:1  |g day:28  |g month:01  |g pages:44-9 
856 4 0 |u http://dx.doi.org/10.1016/j.jsha.2014.09.003  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 27  |j 2015  |e 1  |b 28  |c 01  |h 44-9